Rule 2 Jul 2025 commerce, regulatory changes, economic development, grants, grant programs-housing and community development, federal assistance, community development

🏢Elimination of Supplementary Grant Regulation by Economic Development Administration

Through this final rule, the Economic Development Administration (EDA), U.S. Department of Commerce, is eliminating the regulations on supplementary investment assistance. The regulation is confusing and does not provide any guidance in addition to what is already in section 205 of EDA's enabling statute, the Public Works, and Economic Development Act of 1965.

Learn More
Proposed Rule 2 Jul 2025 compliance, regulation, faa, safety, aircraft, aviation safety, incorporation by reference, air transportation, helicopter, airbus, airworthiness

✈️Proposed Airworthiness Directive for Airbus Helicopters EC 155B

The FAA proposes to adopt a new airworthiness directive (AD) for all Airbus Helicopters Model EC 155B and EC155B1 helicopters. This proposed AD was prompted by a determination that the required forces to jettison the windows exceed the maximum jettisoning effort requirements and the development of a modification of the jettisonable windows. This proposed AD would require replacement of the jettisonable windows and seals on the sliding doors and fixed panels on the left-hand and right- hand sides. This proposed AD would also require the installation of new labels. The FAA is proposing this AD to address the unsafe condition on these products.

Learn More
Notice 2 Jul 2025 regulation, aerospace, usa, antitrust, competition, mergers and acquisitions, rtx, safran

✈️Antitrust Concerns Over Safran's Acquisition of Collins Aerospace

The Department of Justice has fielded a complaint against Safran S.A.'s proposed acquisition of Collins Aerospace citing antitrust violations. The proposed Final Judgment requires Safran to divest its North American actuation business, ensuring the maintenance of competition in the aerospace sector for critical actuators used in large aircraft. Public comments are invited as part of the regulatory process.

Learn More
Rule 2 Jul 2025 regulatory compliance, coast guard, safety zones, northern great lakes, maritime events

🚢Coast Guard Enforcement of Safety Zones in Northern Great Lakes

The Coast Guard will enforce various safety zones for maritime events in the Captain of the Port Northern Great Lakes zone. Enforcement of these safety zones is necessary to protect the safety of life and property on the navigable waters immediately prior to, during, and immediately after these events. During each enforcement period, the Coast Guard will enforce restrictions upon, and control movement of, vessels in the specified areas immediately prior to, during, and immediately after events. During each enforcement period, no person or vessel may enter the respective safety zone without permission of the Captain of the Port Northern Great Lakes or his designated representative.

Learn More
Notice 2 Jul 2025 healthcare, business compliance, fda, regulatory review, medical devices, patent extension

🦴FDA Patent Extension for TOTAL POSTERIOR SPINE SYSTEM

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for TOTAL POSTERIOR SPINE SYSTEM (TOPS SYSTEM) and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that medical device.

Learn More
Notice 2 Jul 2025 compliance, federal regulations, national credit union administration, business risks, criminal regulatory offenses

⚖️NCUA Guidance on Criminal Regulatory Offenses and Compliance

This notice describes the NCUA's plans to address criminally liable regulatory offenses under the recent executive order on Fighting Overcriminalization in Federal Regulations.

Learn More
Proposed Rule 2 Jul 2025 administrative practice and procedure, reporting and recordkeeping requirements, medicare, health professions, health facilities, investigations, rural areas, medicaid, fraud, healthcare compliance, medical devices, grant programs-health, diseases, drugs, biologics, payment rates, quality reporting, x-rays, home health, emergency medical services, durable medical equipment

🏥Medicare and Medicaid Proposed Rule on Home Health Payment Updates

This proposed rule would set forth routine updates to the Medicare home health payment rates in accordance with existing statutory and regulatory requirements. In addition, this proposed rule proposes permanent and temporary behavior adjustments and proposes to recalibrate the case-mix weights and update the functional impairment levels; comorbidity subgroups; and low-utilization payment adjustment (LUPA) thresholds for CY 2026. Lastly, this proposed rule proposes policy changes to the face-to-face encounter policy. It also proposes changes to the Home Health Quality Reporting Program (HH QRP) and the expanded Health Value-Based Purchasing (HHVBP) Model requirements. In addition, it would update the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program (CBP). Lastly it proposes: a technical change to the HH conditions of participation; updates to DMEPOS supplier conditions of payment; updates to provider and supplier enrollment requirements; and changes to DMEPOS accreditation requirements.

Learn More
Notice 2 Jul 2025 sec, regulatory compliance, investment advisers, information disclosure, client relations

📄SEC Rule 204-3

The SEC has submitted a request for an extension of Rule 204-3, which mandates investment advisers to provide specific brochures and updates to clients at the start and annually during their advisory relationship. This rule aids clients in decision-making and assists the SEC in regulatory enforcement. Compliance with this rule represents a significant operational requirement for advisers.

Learn More
Notice 2 Jul 2025 pharmaceuticals, infectious diseases, biotechnology, health innovation, government licensing

💉Government-Owned EV-D68 Antibodies Now Available for Licensing

The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

Learn More
Notice 2 Jul 2025 nasdaq, liquidity, options market, market makers, fees and rebates

📈Nasdaq Options Market Proposed Rule Change on Fees and Rebates

The Nasdaq Stock Market LLC has proposed rule changes to amend its options market fees and rebates, specifically enhancing the incentives for Market Makers who add liquidity in penny symbols. These adjustments aim to foster greater market participation and improve order flow on the Nasdaq Options Market.

Learn More